The crgA gene of Neisseria meningitidis, which codes for a LysR-type regulator, is divergently oriented with respect to the mdaB gene, which codes for a hypothetical NADPH-quinone oxidoreductase. Transcriptional studies of the intergenic region between crgA and mdaB showed that two overlapping and divergent promoters, P crgA and P mdaB , control transcription of these genes. Deletion of the crgA gene led to a strong increase in transcription from the P crgA promoter and a concomitant strong decrease in transcription from the P mdaB promoter, indicating that CrgA acts both as an autorepressor of transcription at its own promoter and as an activator of transcription at the mdaB promoter. Addition of ␣-methylene-␥-butyrolactone (MBL), an inducer of NADPH-quinone oxidoreductase, to wild-type N. meningitidis cells specifically resulted in further activation of transcription of the P mdaB promoter and more repression of transcription of the P crgA promoter. No such regulation was observed when MBL was added to crgA-deficient cells, indicating that the transcriptional response to MBL is CrgA mediated. Under the same experimental conditions, no regulation of transcription by either CrgA or MBL was detected at the pilus and capsule genes. The role of CrgA in the regulation of gene expression during the infectious cycle of N. meningitidis is discussed.
The human pathogen Neisseria meningitidis is a common colonizer of the nasopharynx, and in a small percentage of carriers, this bacterium can cross the epithelial barrier to enter the bloodstream, causing septicemia, and then further cross the blood-brain barrier, causing meningitis. The ability to interact with host cells plays a major role in the ability of N. meningitidis to establish a productive infection. Numerous bacterial attributes have been identified as factors that play a role in these interactions. Among these, the type IV pili play an essential role by allowing the initial adhesion of bacteria to host cells via the adhesin PilC1 (20, 22) . The expression of PilC1 is upregulated during the initial interaction of the bacteria with the cells; this upregulation is required for complete adhesion of the bacterium (28) . It has been proposed that regulation of PilC1 expression is controlled by a 150-bp sequence located upstream of pilC1. This 150-bp element was designated CREN, for contact regulatory element of Neisseria (28) . Further analysis demonstrated that a 150-bp sequence very similar to that found upstream of pilC1 corresponds to a sequence repeat, designated Rep2, containing a ribosome binding site upstream of an ATG codon, which is the predicted start codon of a downstream open reading frame (ORF) (23) . This full-length element is present 16 times in the N. meningitidis genome. Fourteen of 16 ORFs located downstream of Rep2 are upregulated during the initial contact of the bacteria with the cells in a manner similar to that of pilC1 (21) , suggesting that these 14 Rep2-associated genes are coordinately upregulated in the initial interaction of N. meningitidis with host cells. Interestingly, one of the CREN/Rep2 elements lies upstream of a gene designated crgA (contact-regulated gene A) (7) , which encodes a 299-amino-acid protein belonging to the LysR family of transcriptional regulators (14, 26, 32) .
It has been reported that in the absence of epithelial cells, crgA is expressed at low levels from two transcription start sites, P1 and P2, which map upstream of and within the CREN/ Rep2 element, respectively. RNA analyses led to the hypothesis that transcription starting at P2 is responsible for inducing crgA expression when N. meningitidis comes into contact with target cells (7) . As a consequence, it has been proposed that the product of this gene, CrgA, represses the expression of several genes, including the pilC1, pilE, and sia genes involved in adhesin, pilin, and capsule biosynthesis, respectively. However, there are reasons to doubt aspects of the previous model. For example, the transcript starting at the P2 site poorly resembles the Ϫ24/Ϫ12 GG-N 10 -GC consensus sequence characteristic of a sigma 54-dependent promoter (1) . Furthermore, in N. meningitidis the sigma 54 factor encoded by the rpoN gene is inactive (17, 29) , and in vitro the P2 promoter appears to be transcribed by the Escherichia coli RNA polymerase containing sigma 70, the housekeeping sigma factor (4) . Although it has been suggested that the P1 and P2 transcriptional start sites of the crgA gene arise from two distinct promoters, no functional evidence has been provided yet, and the nature of the mapped 5Ј ends of RNA remains unclear.
CrgA has been reported to function by binding to the pro-moters of the crgA and pilC1 genes (both harboring a CREN/ Rep2 element), as well as the pilE and sia genes (both devoid of a CREN/Rep2 element), repressing transcription upon adhesion of bacteria to target epithelial cells (5) . This suggested that, independent of the CREN/Rep2 element, CrgA regulates all four promoters by a similar mechanism (3, (5) (6) (7) , possibly by binding to a T-N 11 -A motif characteristic of other LysR regulators (9) . In this paper, we report functional identification of the crgA gene promoter and provide evidence that the CREN/Rep2 repeat element is not involved in initiation of gene transcription. We show that CrgA is a regulatory protein controlling transcription both as a repressor and as an activator of overlapping and divergent promoters. Furthermore, activation and repression of transcription controlled by CrgA are enhanced by the addition of an inducer of NADPH-quinone oxidoreductase to N. meningitidis cells. It is likely that this inducer, or a similar inducer, activates the CrgA protein to control the expression of sets of genes; however, transcription of pilus and capsule genes appeared to be unaltered irrespective of CrgA and ␣-methylene-␥-butyrolactone (MBL).
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in this study are listed in Table 1 . The N. meningitidis strains are MC58 derivatives (29) and were routinely cultured in GC-based (Difco) agar supplemented with Kellogg's supplement I (15) at 37°C in a 5% CO 2 -95% air atmosphere at 95% humidity. Strains were stocked in 10% skim milk and stored at Ϫ80°C. For liquid cultures, N. meningitidis strains were grown overnight on solid medium, resuspended in phosphate-buffered saline (PBS) to an optical density at 600 nm of 1, and inoculated at a 1:20 dilution into GC broth supplemented with Kellogg's supplement I, 12.5 M Fe(NO 3 ) 3 , and, when required, erythromycin, kanamycin, and/or chloramphenicol added at final concentrations of 5, 100, and 5 g/ml, respectively. For transformation by naturally competent N. meningitidis, four or five single colonies of a freshly grown overnight culture were resuspended in 20 l of PBS, spotted onto GC agar plates to which 5 to 10 g of linearized plasmid DNA was added, allowed to dry, and incubated for 6 to 8 h at 37°C. Transformants were then selected on plates containing erythromycin (5 g/ml), kanamycin (150 g/ml), and/or chloramphenicol (5 g/ml), and single colonies were restreaked on selective media for further analysis. Single colonies were resuspended in 50 l of distilled water, placed in a boiling water bath for 5 min, and centrifuged in a bench top centrifuge for 5 min at 8,000 ϫ g. One microliter of the sample was used as a template for PCR analysis. E. coli DH5␣ cultures were grown in Luria-Bertani medium, and when required, ampicillin, kanamycin, and chloramphenicol were added at final concentrations of 100, 25, and 30 g/ml, respectively. DNA techniques. DNA manipulations were carried out routinely as described by Sambrook et al. (25) . Small-scale plasmid DNA preparation and large-scale plasmid DNA preparation were carried out with a QIAprep Spin mini kit and a plasmid midi kit (QIAGEN, Inc.) used according to the manufacturer's instructions. DNA fragments or PCR-amplified products were purified from agarose gels with a QiaEX DNA purification kit (QIAGEN, Inc.). Each PCR was performed with a Perkin-Elmer 2400 thermal cycler with Platinum Taq polymerase (Invitrogen). One microliter of each reaction mixture contained 10 to 50 ng of chromosomal DNA or 1 l of bacterial sample (see above), 100 pmol of the required primers, and 200 M of each deoxynucleotide in 100 l of 1ϫ PCR buffer containing MgCl 2 (New England Biolabs, Inc.). After the initial denaturing step at 95°C for 5 min, 30 cycles of denaturation at 95°C, annealing at the appropriate temperatures for the specific primers, and elongation at 72°C were carried out. DNA fragments were sequenced by the dideoxy chain termination method by using [␣-32 P]dATP (Amersham) and a T7 sequencing kit (Pharmacia).
Construction of chromosomally located transcriptional lacZ fusions. To generate transcriptional lacZ fusions of the promoters studied at a chromosomal location between two converging ORFs, NMB1074 and NMB1075, a series of plasmids for allelic exchange in N. meningitidis strains were constructed (Table  1) . A plasmid consisting of a promoterless lacZ gene and the ermAM erythromycin resistance genes flanked by upstream and downstream regions for allelic replacement was generated by cloning fragments into the multiple-cloning site of the pSL1190 vector in the following order: a 510-bp SpeI-XhoI fragment consisting of the upstream flanking region amplified from MC58 chromosomal DNA with primers Fla-UP-L and Fla-UP-R (Table 2 ), a 1.1-kb XhoI-PstI fragment carrying the ermAM genes amplified from plasmid pAT110 using primers Eryt-DO and Eryt-UP, a 3.4-kb SmaI-BamHI fragment carrying the lacZ gene from pCMV␤, and a 909-bp BamHI-XmaI fragment consisting of a downstream flanking region amplified from the MC58 chromosome with primers Fla-DO-L and Fla-DO-R. This plasmid was named pSL-Fla-Ery. The promoter region of crgA or portions of this region were then amplified with primer pairs Pcrg1R-N-Pcrg1L, Pcrg2R-N-Pcrg1L, Pcrg3R-N-Pcrg1L, Pcrg4R-N-Pcrg1L, and Pcrg1R-N-Pcrg2L and cloned as an NsiI-SphI fragment in pSL-Fla-Ery. The resulting plasmids were designated pSL-Pcrg1, pSL-Pcrg2, pSL-Pcrg3, pSL-Pcrg4, and pSL-Pcrg5, respectively (Table 1) . These plasmids were used for transformation of the MC58 strain. Transformants were first selected for erythromycin resistance and then tested for the double-crossover at the flanking regions by PCR using primer pairs Fla-UP-C-Ery-DO-C and Fla-DO-C2-LAC-DO-C. The resulting strains were wtA (MC-P crgA 1), ⌬35 (MC-P crgA 2), ⌬10 (MC-P crgA 3), ⌬P (MC-P crgA 4), and ⌬R (MC-P crgA 5), respectively ( Table 1) . Construction of the crgA mutant of N. meningitidis and complementation. To construct a crgA deletion mutant, the crgA gene was replaced with a kanamycin cassette by double crossing over. To do this, plasmid pG3cr:Km was generated as follows. Upstream and downstream flanking regions of crgA were amplified from the MC58 chromosome with primer pairs crup-L2-crup-R2 and crdw-L-crdw-R and cloned as 428-bp PstI/BamHI and 489-bp BamHI/EcoRI fragments into pGem3Z, respectively; a kanamycin cassette from plasmid pILL600 was cloned as a 1.4-kb BamHI fragment into the BamHI site between the two flanking regions. This plasmid was used to transform N. meningitidis strain ⌬R (MC-P CrgA 5). Transformants were selected for kanamycin resistance and analyzed by PCR for correct insertion by a double homologous recombination event. The resulting mutant was named ⌬RCrgA (MC-C Ϫ P crgA 5). Complementation of CrgA was achieved by insertion of a copy of the crgA gene under the control of the inducible promoter P tac and the LacI repressor in the noncoding region of the ⌬RCrgA (MC-C Ϫ P crgA 5) chromosome between the converging ORFs NMB1428 and NMB1429. To do this, a 500-bp XmaI/NsiI fragment downstream of NMB1428 and a 430-bp BamHI/SpeI fragment upstream of NMB1429 were amplified with oligonucleotides Com1 and Com2 and oligonucleotides Com3 and Com4, respectively. These fragments are consecutive fragments that have overlapping ends bearing the BamHI and NsiI restriction sites for cloning purposes. These two fragments were used as templates to amplify an 885-bp XbaI/BamHI fragment with the Com1 and Com4 primers, which was cloned as an XmaI/SpeI fragment in pSL1190. Subsequently, an 800-bp XbaI/BamHI fragment containing the chloramphenicol resistance cassette was added to this construct, generating plasmid pSLComCmr. The 1,550-bp BamHI/NsiI lacI-P tac region was amplified from plasmid pMMB206 with oligonucleotides Pind-F and Pind-R, and a 910-bp NdeI/NsiI fragment of the crgA gene was amplified from N. meningitidis strain MC58 with oligonucleotides CrgA-N and Crg-R. The PCR products were cloned in the BamHI/NdeI sites of the pSLComCmr plasmid. The resulting plasmid, pPindcrgA, was used to transform ⌬RCrgA (MC-C Ϫ P crgA 5). Transformants were selected for chloramphenicol resistance, and correct insertion was verified by PCR. The selected strain was named ⌬RCrgA-C (MC-C Ϫ CindP crgA 5). Induction of the protein was achieved by growing the strain in GC broth with isopropyl-␤-D-thiogalactopyranoside (IPTG) to the logarithmic phase.
Primer extension analysis. An oligonucleotide (3 pmol) was 5Ј end labeled in the presence of [␥-
32 P]ATP (5,000 Ci/mmol; Perkin-Elmer) and T4 polynucleotide kinase (New England Biolabs). One hundred femtomoles of the labeled oligonucleotide was coprecipitated with 30 g of total RNA and resuspended in 5 l of water, 2 l of 2 mM deoxynucleoside triphosphates, and 2 l of 5ϫ reverse transcription buffer (Roche). The mixture was incubated for 2 min at 95°C and for 1 min at room temperature, and then reverse transcription was started by adding 1 l of reverse transcriptase (Roche) and incubating the reaction mixture at 45°C for 45 min. The sample was then incubated for 10 min at room temperature with 1 g of RNase A for RNA digestion, extracted once with an equal volume of phenol-chloroform (1:1), ethanol precipitated, and resuspended in 5 l of sequencing loading buffer. After denaturation at 95°C for 2 min, samples were subjected to 6% urea-polyacrylamide gel electrophoresis and autoradiographed. S1 nuclease mapping. A 441-bp probe corresponding to the promoter region of crgA and the 5Ј region of the crgA gene (Probe1) (Fig. 1A) , labeled at the 5Ј end of the noncoding strand, was obtained by PCR amplification with the primer pair NMB1856L-NMB1856R, 5Ј end labeled in the presence of [␥-32 P]ATP and T4 polynucleotide kinase (New England Biolabs), and subsequently digested with SspI. Approximately 20 fmol of the probe was coprecipitated with 40 g of total N. meningitidis RNA and resuspended in 20 l of hybridization buffer (80% formamide, 60 mM Tris-HCl, pH 7.5, 400 mM NaCl, 0.4 mM EDTA). The mixture was overlaid with 5 l of mineral oil, denatured at 100°C for 2 min, and incubated overnight at 55°C. Subsequently, 180 l of ice-cold S1 buffer (33 mM sodium acetate, pH 5.2, 5 mM ZnSO 4 , 250 mM NaCl) and 1 l of S1 nuclease (150 U/l; Invitrogen) were added, and digestion was carried out for 30 min at 37°C. Samples were extracted with phenol-chloroform (1:1), ethanol precipitated, and resuspended in 5 l of sequencing buffer. After denaturation at 95°C for 2 min, samples were subjected to 6% urea-polyacrylamide gel electrophoresis and autoradiographed.
Western blot analysis. To prepare sera against CrgA, 20 g of recombinant CrgA protein obtained under denaturing conditions was used to immunize 6-week-old CD1 female mice (Charles River Laboratories) according the procedure described by Pizza et al. (24) . One milliliter of a single culture in the exponential growth phase was harvested by centrifugation at 8,000 ϫ g and resuspended in 100 l of sodium dodecyl sulfate-polyacrylamide gel electrophoresis loading buffer, and 5 l of each total protein sample was fractionated on 
RESULTS
Intergenic region between the crgA and mdaB genes of N. meningitidis contains two overlapping and divergent promoters. The structure of the locus and the nucleotide sequence of the 238-bp intergenic region between the two divergent genes crgA and mdaB are shown in Fig. 1 . This region contains a 138-bp DNA element, termed Rep2 or CREN (21, 28) , directly upstream of the putative ATG start codon of the crgA gene. To define the start point of transcription of crgA and mdaB, we carried out an S1 nuclease protection assay and primer extension analysis for total RNA extracted from N. meningitidis. Figure 2A shows the results of urea-acrylamide gel electrophoresis in an S1 nuclease protection experiment carried out by hybridizing Probe1 (Fig. 1A) to RNA of wild-type N. meningitidis. The results show a major S1-resistant band migrating at a position corresponding to 375 nucleotides, which defined the P crgA start site of transcription ( Fig. 2A, lane 2) . Other faster-migrating bands may have been derived from the presence of weaker start points or from in vivo degradation of the RNA, and most of these 5Ј ends of RNA mapped within the CREN/Rep2 region. Primer extension analysis (Fig. 2D , lane 5) confirmed the position of the P crgA start site of transcription at a position 179 nucleotides from the ATG start codon of the crgA gene and minor 5Ј ends of RNA mapping within the CREN/Rep2 element.
To define the start point of the mRNA encoded by the mdaB gene, we carried out primer extension of total RNA extracted from N. meningitidis. Figure 2B shows a unique extended product mapping at a position 24 nucleotides upstream of the ATG start codon of the mdaB gene, indicating the position of the P mdaB start site of RNA transcription.
These results indicate that the intergenic region between the crgA and mdaB genes contains at least two promoters, which we called P crgA and P mdaB . Analysis of the DNA sequence revealed the presence of Ϫ10-TATAAT and Ϫ35-ATGAAT regions upstream of P crgA and Ϫ10-CACAAT and Ϫ35-TTT TAA regions upstream of P mdaB . These sequences show conservation with the E. coli sigma 70 Ϫ10-TATAAT and Ϫ35-TTGACA recognized promoters and are likely to define the N. meningitidis P crgA and P mdaB promoters (Fig. 1B) . Analysis of the sequences upstream of the 5Ј ends mapping within the CREN/Rep2 element revealed no sequence conservation with known promoter consensus sequences.
In order to obtain information on the nature of the 5Ј ends of transcripts mapping downstream of the P crgA promoter, we generated progressive deletions of the P crgA promoter region fused to lacZ, introduced into the N. meningitidis MC58 genome by double recombination, and assayed for activity. As the beta-galactosidase activity values were very close to the background levels for all constructs, we decided to investigate transcription by primer extension analyses. Figure 2C shows a diagrammatic representation of the strains harboring the P crgA deletion mutations. Total RNA was extracted from each mutant strain and used in primer extension analyses. Figure 2D shows that the P crgA promoter was active in the strain carrying the full-length promoter construct (strain wtA) (lane 1), as well as in the strain carrying the deletion of the CREN/Rep2 region (strain ⌬R) (lane 5). No extension products were detected with RNA extracted from strains ⌬35, ⌬10, and ⌬P (lanes 2, 3, and 4), which harbored deletions from position Ϫ63 to position Ϫ15, from position Ϫ63 to position Ϫ6, and from position Ϫ63 to position 43 of P crgA , respectively. Therefore, transcription of the region studied was abolished when deletions affected the Ϫ35 or Ϫ10 regions of the P crgA promoter. Consequently, we concluded that the 5Ј ends mapping within the CREN/Rep2 region are P crgA dependent and that no promoters map within this region. These results were confirmed by primer extension of RNA extracted from E. coli transformed with plasmids carrying the crgA promoter mutations (data not shown). Furthermore, five independent beta-galactosidase experiments with the E. coli system gave Miller unit values of 61.5 Ϯ 6.3, 6.8 Ϯ 1.4, 9.8 Ϯ 1.6, 5.4 Ϯ 1.2, and 98.4 Ϯ 3.3 for the wtA, ⌬35, ⌬10, ⌬P, and ⌬R constructs, respectively.
We concluded that the crgA gene is transcribed from the P crgA promoter upstream of the Rep2/CREN element.
CrgA represses transcription from P crgA and activates transcription from P mdaB . To establish the role of CrgA in transcription of the P crgA and P mdaB promoters, we decided to assay transcription from these promoters in a crgA deletion mutant. To do this, we substituted the crgA gene with a kanamycin cassette in strain ⌬R (Fig. 2C) , which carried the P crgA promoter fused to lacZ in a heterologous locus, generating strain ⌬RCrgA ( Table 1) . Expression of CrgA in these strains was assessed by Western blot analysis of total protein extracts, whereas transcription from the P crgA and the P mdaB promoters was assayed by primer extension analysis. Figure 3A shows a Western blot of protein extracts from strains ⌬R (CrgA ϩ ) and ⌬RcrgA (CrgA Ϫ ). As expected, in the wild-type background a protein band corresponding to CrgA was detected (lane 1), while this band was not detected in the crgA deletion mutant (lane 2).
Total RNA was extracted from these strains, and primer extension was carried out with primers hybridizing to RNA synthesized from the P crgA and P mdaB promoters in the heterologous genomic location. Figure 3B shows that transcription from the P crgA promoter was increased in the CrgA mutant (lane 2) compared to RNA extracted from the wild-type background (lane 1). Surprisingly, the amount of transcripts at the P mdaB promoter was strongly reduced and transcripts were undetectable in the CrgA mutant (lane 2) compared to the wild-type background (lane 1). As a control, primer extension was carried out with a primer complementary to the adenylate kinase gene (adk), and this experiment showed no variation in the amount of mRNA (lanes 1 and 2) . These results indicate that CrgA represses transcription from the P crgA promoter and activates transcription from the P mdaB promoter.
Complementation of the crgA mutation. To complement the crgA mutation and to obtain a better understanding of the regulation of transcription by CrgA, we constructed a strain expressing the crgA gene under the control of an inducible promoter to monitor accumulation of the CrgA protein and VOL. 187, 2005 CrgA OF N. MENINGITIDIS 3425 on August 15, 2017 by guest http://jb.asm.org/ correlate it to regulation of transcription. In this strain, ⌬RCrgA-C (Table 1) , the expression of the crgA gene was inducible by addition of IPTG, as its transcription was under the control of the P tac promoter and the LacI repressor. Cells were grown in liquid cultures in the presence of increasing amounts of IPTG to the mid-log phase, and aliquots of each sample were collected and used to prepare total protein extracts and total RNA. The Western blot in Fig. 4A shows that the CrgA protein was detected when cells were grown in the presence of 10 M IPTG (lane 2) and that the amount increased with increasing amounts of IPTG in the culture medium (lanes 3 to 4) . Primer extension analysis showed that transcription from the P crgA promoter was repressed in cells grown in the presence of 30 M IPTG or in the presence of higher concentrations of IPTG (Fig. 1A) was end labeled at one extremity, hybridized to N. meningitidis total RNA, and used for S1 nuclease digestion to map 5Ј ends of transcription products synthesized by the P crgA promoter. The GϩA lane contained a GϩA sequence reaction mixture for the DNA probe used as a size marker (18) . A control sample was processed identically but contained no RNA (lane 1). Lane 2 contained 40 g RNA. The nucleotide sequence of the coding strand upstream of the transcriptional start site is shown on the right, and the Ϫ10 promoter element is indicated by a vertical bar. The P crgA promoter in strain MC58 appears to be localized 10 bp upstream of the P1 promoter mapped by Deghmane and coworkers (7) in strain C8013. The nature of this discrepancy was not investigated. (B) Identification of mdaB transcript. Total RNA (30 g) from N. meningitidis was hybridized to the end-labeled mdaB-PE oligonucleotide (Table 2 ) and elongated with reverse transcriptase to map 5Ј ends of transcription products synthesized by the P mdaB promoter (lane 1). Precise mapping was performed by sequencing the cloned region in plasmid pG3cr:Km (Table 1) with the same primer (lanes G, A, T, and C). DNA regions corresponding to promoter and Rep2/CREN elements are indicated on the left. (C) Schematic representation (not to scale) of the chromosomal promoter-Rep2 mutations fused to the lacZ gene and inserted between the NMB1074 and NMB1075 ORFs of the N. meningitidis genome. The strains are referred to by their short names; the full names are given in Table 1 . (D) Detection of the transcript generated by the promoter-Rep2 mutations fused to lacZ. Lanes 1 to 5 contained 30 g of total RNA extracted from strains wtA, ⌬35, ⌬10, ⌬P, and ⌬R, respectively, hybridized to the end-labeled LAC oligonucleotide (Table 2), and elongated with reverse transcriptase. Lanes 1 and 5 contained RNA synthesized by the P crgA promoter; no bands were de- (Table 1) with primer LAC (lanes G, A, T, and C) .
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( Fig. 4B, compare lanes 3 and 4 with lanes 1 and 2) . By contrast, at the same concentrations of IPTG the P mdaB promoter was increasingly activated (Fig. 4C, lanes 1 to 4) . In a control experiment, transcription from the adk promoter showed no variation in the amount of RNA in response to IPTG (data not shown). We concluded that CrgA controls transcription from the P crgA and P mdaB promoters in a dosedependent manner. Activity of the CrgA regulator is induced by ␣-methylene-␥-butyrolactone. In E. coli, the mdaB gene encodes a protein with NADPH-specific quinone oxidoreductase activity that has been shown to be induced more than 25-fold by MBL (13) . To investigate whether addition of this small molecule to N. meningitidis cells influences transcription of the mdaB gene in a CrgA-dependent manner and in turn transcription of the crgA gene, we extracted RNA from the wild-type background (⌬R), the crgA mutant (⌬RCrgA), and the complementing (⌬RCrgA-C) strains before treatment and after 10 min of treatment of the cells with 2 mM MBL. These RNA preparations were used in primer extension experiments to monitor accumulation of RNA at the P mdaB and P crgA promoters, and the results are shown in Fig. 5 .
Treatment of the ⌬R strain (CrgA ϩ ) with MBL clearly resulted in an increase in the amount of transcript from the P mdaB promoter (Fig. 5A, lanes 1 and 2) . Independent of MBL addition, no extended products were detected in the CrgA mutant ( lanes 3 and 4) ; however, the pattern of RNA accumulation in response to MBL was restored in the CrgA complemented strain (CrgA Ϫ C) (lanes 5 and 6). The same RNA preparations were then used in primer extension experiments to monitor transcription from the P crgA promoter. Figure 5B shows that in the wild-type background, the amount of transcript from the P crgA promoter was decreased upon MBL treatment (lanes 1 and 2) and was not influenced in the mutant (lanes 3 and 4) and that these changes could be complemented by CrgA (lanes 5 and 6).
From these results, we concluded that addition of MBL to growing cells activates transcription of the P mdaB promoter and represses transcription from the P crgA promoter. Furthermore, these modulations of transcription are CrgA dependent.
CrgA and MBL have no effect on transcription of pilus and capsule genes. The results described above prompted us to investigate whether other CrgA-regulated promoters are similarly regulated. As it has been reported that CrgA regulates transcription of the pilC1, pilE, and sia genes (5), we selected these genes to study the CrgA-mediated MBL response. To do this, we carried out primer extensions of the pilE, sia, and pilC1 mRNA using the same RNA sample that was used for the experiment whose results are shown in Fig. 5 , and the results are shown in Fig. 6 . Figure 6A shows the extended products of the pilE mRNA, with a major band mapping 90 nucleotides upstream of the ATG start codon, which identified the P pilE start site of RNA transcription. This is in agreement with previous studies (2) . Surprisingly, regardless of MBL addition to the cells the intensity of this band remained unchanged in the three strains used (lanes 1 to 6). Figure 6B shows two extended products of the sia mRNA, with a major band identifying the P sia start site of VOL. 187, 2005 CrgA OF N. MENINGITIDIS 3427 RNA transcription 106 nucleotides upstream of the ATG start codon. This corresponds to a previously identified promoter (27) , which showed no variation in the amount of RNA among strains or upon MBL treatment (lanes 1 to 6). Figure 6C shows the extended products of the pilC1 mRNA. The slowly migrating band mapped 255 nucleotides upstream of the ATG start codon of the gene and corresponded to the P pilC1 start site of RNA transcription (28) . This band and the faster-migrating bands had similar intensities in RNA extracted from the three strains and from cells treated or not treated with MBL (lanes 1 to 6). These results indicate that transcription from the pilC1, pilE, and sia promoters is regulated neither by CrgA nor by MBL addition. It is worth noting that the 5Ј ends mapping downstream of the P pilC1 promoter are located in the CREN/Rep2 region of the pilC1 gene; thus, analogous to results obtained for the P crgA promoter (Fig. 2) , these 5Ј ends of RNA and those mapping downstream of the P pilE promoter may arise from in vivo processing of longer mRNAs.
DISCUSSION
The CrgA protein of N. meningitidis is a LysR-type transcriptional regulator (29) , which is upregulated during the initial phase of adhesion of the bacterium to the target cells, and this protein was proposed to be a repressor controlling expression of a set of genes during bacterial adhesion to epithelial cells (7) . The gene encoding the CrgA regulator, crgA, is preceded by a CREN/Rep2 repetitive DNA element and maps divergently with respect to another gene, the mdaB gene coding for an NADPH-quinone reductase.
In this study, we identified a single promoter, P crgA , which is responsible for transcription of the crgA gene. We carried out deletion and 5Ј end mapping analyses, which showed that the 5Ј ends of transcripts mapping within the CREN/Rep2 region depend on transcription from the upstream P crgA promoter (Fig. 2) . Furthermore, the P mdaB promoter of the upstream gene is divergently oriented and overlaps the P crgA promoter ( Fig. 1 and 2 ). This promoter architecture is compatible with coordinated regulation of transcription of the crgA and mdaB genes. Accordingly, the amounts of transcripts synthesized from the P crgA and P mdaB promoters are increased and decreased in a crgA knockout background, respectively (Fig. 3) . Furthermore, repression of the P crgA promoter and activation of the P mdaB promoter are restored in a complementing strain (Fig. 4) . In addition, the degree of complementation of the P crgA and P mdaB transcriptional regulation correlates well with the intracellular amount of CrgA (Fig. 4) . Thus, the autoregulatory mechanism of gene transcription primarily controls the intracellular concentration of CrgA, a condition used by many regulatory proteins to modify their activities in response to environmental changes. In addition, CrgA activates the divergently oriented upstream gene, another typical feature of LysR-type regulators. Interestingly, two CrgA binding sites have been mapped within this region (4, 5) . One CrgA binding site spans positions Ϫ16 to 13 of the P crgA promoter, and this region corresponds to positions Ϫ20 to Ϫ49 of the P mdaB promoter. Another CrgA binding site spans positions 17 to 46 of the P crgA promoter that correspond to positions Ϫ53 to Ϫ82 of the P mdaB promoter (Fig. 1B) . Therefore, the two CrgA FIG. 6 . Mapping and regulation of the pilE, sia, and pilC1 promoters. Primer extension analyses were performed with the same RNA used for the experiment shown in Fig. 5 and with primers pilE-PE1 (A), sia-PE1 (B), and pilC-PE2 (C) to assess regulation of the P pilC1 , P pilE , and P sia promoters, respectively. Sequencing reactions carried out with each cloned promoter fragment served as size markers (lanes G, A, T, and C). Independent of the strain and of MBL treatment, major bands show no appreciable variation in the amount of elongated products. Analyses of the DNA sequence upstream of the identified major bands revealed the presence of Ϫ10 and Ϫ35 regions similar to the E. coli sigma 70 consensus sequences, Ϫ10-TATAAT and Ϫ35-TTGACA. While no promoter consensus sequences were identified upstream of the other 5Ј ends of RNA mapping downstream of the P pilE and P pilC1 promoters, a putative promoter sequence, AATAAA-N 17 -TATAAT, was detected upstream of the 5Ј end of RNA mapping 48 nucleotides upstream of the sia genes (faster-migrating band in panel B).
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on August 15, 2017 by guest http://jb.asm.org/ binding sites are located close to the transcriptional start site of the P crgA promoter and upstream of the P mdaB promoter, respectively. These DNA binding positions could be compatible with a mechanism of repression and activation of transcription of the P crgA and P mdaB promoters, respectively. It has been proposed that a second promoter, termed P2, controls expression of the crgA gene mapping within the Rep2/ CREN element (7). We have no evidence of promoters mapping within this region. The possibility that this element is responsible for posttranscriptional regulation of crgA upon cell contact should be considered. Indeed, mRNA processing and degradation by nucleases depend on the secondary structure, including the presence of stem-loops at the 5Ј ends (11) . Accordingly, a transcript carrying a CREN/Rep2 region at its 5Ј end might fold into a secondary structure that could be targeted by specific nucleases during cell contact, resulting in changes in the stability of mRNA. This hypothesis could account for the observed upregulation of transcripts mapping at the P2 site described by Deghmane and coworkers (7) .
It has been reported that the activity of the NADPH-quinone reductase encoded by the mdaB gene of E. coli is induced more than 25-fold by the addition of MBL to growing cells (13) . As this could result from increased expression of the enzyme, we decided to investigate the effect of MBL on transcription of the CrgA-regulated gene promoters in N. meningitidis. Indeed, cells treated with MBL showed strong induction of transcription from the P mdaB promoter and, in parallel, strong repression of the P crgA promoter, and both induction and repression were CrgA dependent (Fig. 5 ). This suggests that MBL could act as a cofactor or effector molecule that activates the CrgA regulatory protein. Interestingly, transcriptome analyses have highlighted the finding that transcription of the mdaB gene is increased upon interaction of N. meningitidis with epithelial cells (8, 10) . Therefore, it is tempting to speculate that MBL or a similar molecule could be available to N. meningitidis during adhesion to activate CrgA, which in turn would control transcription of a specific set of genes.
It has been reported that CrgA functions by binding to the promoters of the pilC1, pilE, and sia genes in the regions spanning positions Ϫ94 to Ϫ58, Ϫ163 to Ϫ133, and Ϫ39 to 13 with respect to the corresponding transcriptional start sites, respectively (3, 5) . Consequently, we investigated the effect of MBL-specific and CrgA-dependent regulation of transcription of these genes (Fig. 6) . Surprisingly, independent of the CrgA protein, transcription of these genes was not altered in cells treated with MBL. These results do not exclude the possibility that pilC1, pilE, and sia could be regulated by CrgA in response to cell contact. However, it is interesting that while transcription of mdaB and crgA is regulated by CrgA and in response to MBL in a CrgA-dependent manner, transcription of pilC1, pilE, and sia is not affected by CrgA or by addition of MBL to cultured cells. These results are compatible with two hypotheses: (i) regulation by CrgA occurs only upon cell contact by perception of a signal that activates CrgA in a fashion different from that observed for MBL, and (ii) the CrgA binding observed in vitro at these promoters does not occur in vivo or has no biological significance. In support of the latter hypothesis are the findings of Morelle and coworkers (21) , who demonstrated that a crgA mutant was capable of adhering to the same extent as the wild-type strain, thus providing functional evidence that pilus expression is not controlled by crgA during bacterial adhesion to eukaryotic cells. Furthermore, these workers reported that the crgA mutant loses its pili during late adhesion stages at a rate similar to that observed with the wild-type strain, thus demonstrating that downregulation of pili is not via crgA (21) .
In conclusion, we established that CrgA acts as a repressor of transcription of its own gene and as an activator of transcription of the mdaB gene and that its action is enhanced by the presence of MBL. As crgA is upregulated during the initial phase of adhesion (5), it would be interesting to understand the role of MBL or a similar inducer in the coordination of CrgA-regulated genes during infection.
